---
figid: PMC6366304__JCO.2014.59.0018f1
figtitle: Common PI3K pathway aberrations found in a variety of solid tumor types
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC6366304
filename: JCO.2014.59.0018f1.jpg
figlink: /pmc/articles/PMC6366304/figure/F1/
number: F1
caption: Common PI3K pathway aberrations found in a variety of solid tumor types.
  Activation of the PI3K pathway contributes to tumor growth, survival, and resistance
  to anticancer therapies. FGFR2, fibroblast growth factor receptor 2; GBM, glioblastoma
  multiforme; HER2, human epidermal growth factor receptor 2; HNSCC, head and neck
  squamous cell carcinoma; INPP4B, inositol polyphosphate 4-phosphatase type II; MET,
  hepatocyte growth factor receptor; mTORC, mammalian target of rapamycin complex;
  NSCLC, non–small-cell lung cancer; PI3K, phosphoinositide 3-kinase; PIP2, phosphatidylinositol
  4,5-bisphosphate; PIP3, phosphatidylinositol 3,4,5-trisphosphate; PTEN, phosphatase
  and tensin homolog; PTPN12, protein tyrosine phosphatase nonreceptor 12; RTK, receptor
  tyrosine kinase; SCLC, small-cell lung cancer; TNBC, triple-negative breast cancer.
  Adapted from a figure provided by Ana Maria Gonzalez-Angulo.
papertitle: Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors.
reftext: Patricia Mucci LoRusso. J Clin Oncol. 2016 Nov 1;34(31):3803-3815.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8770816
figid_alias: PMC6366304__F1
figtype: Figure
redirect_from: /figures/PMC6366304__F1
ndex: 4552e893-dea6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6366304__JCO.2014.59.0018f1.html
  '@type': Dataset
  description: Common PI3K pathway aberrations found in a variety of solid tumor types.
    Activation of the PI3K pathway contributes to tumor growth, survival, and resistance
    to anticancer therapies. FGFR2, fibroblast growth factor receptor 2; GBM, glioblastoma
    multiforme; HER2, human epidermal growth factor receptor 2; HNSCC, head and neck
    squamous cell carcinoma; INPP4B, inositol polyphosphate 4-phosphatase type II;
    MET, hepatocyte growth factor receptor; mTORC, mammalian target of rapamycin complex;
    NSCLC, non–small-cell lung cancer; PI3K, phosphoinositide 3-kinase; PIP2, phosphatidylinositol
    4,5-bisphosphate; PIP3, phosphatidylinositol 3,4,5-trisphosphate; PTEN, phosphatase
    and tensin homolog; PTPN12, protein tyrosine phosphatase nonreceptor 12; RTK,
    receptor tyrosine kinase; SCLC, small-cell lung cancer; TNBC, triple-negative
    breast cancer. Adapted from a figure provided by Ana Maria Gonzalez-Angulo.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ERBB2
  - FGFR2
  - PIK3R1
  - PIK3CA
  - SCLC1
  - PTEN
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - CUX1
  - SART3
  - AKT1
  - AKT2
  - AKT3
  - INPP4B
  - MTOR
  - RPTOR
  - PTPN12
  - her2
  - fgfr2
  - pik3r1
  - pik3ca
  - ptenb
  - ddx3xb
  - akt1
  - inpp4b
  - ptpn12
  - ptpn22
  - Cancer
---
